导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.47% | 78/354 |
| 近一周 | -1.92% | 98/362 |
| 近一月 | -4.63% | 233/362 |
| 近一季 | -2.87% | 157/362 |
| 近半年 | 4.65% | 184/358 |
| 近一年 | 9.58% | 149/349 |
| 近两年 | 5.05% | 280/314 |
| 近三年 | 28.11% | 150/246 |
| 成立以来 | 87.39% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.94% 28/360 |
10.88% 129/366 |
- - |
- - |
| 2025 | 0.81% 307/358 |
0.21% 179/340 |
-1.48% 257/348 |
4.06% 301/354 |
-1.87% 190/358 |
| 2024 | 6.30% 203/329 |
-0.68% 176/280 |
-0.37% 202/310 |
14.47% 111/318 |
-6.16% 248/329 |
| 2023 | 10.74% 82/275 |
1.95% 99/205 |
2.11% 112/230 |
-7.22% 196/262 |
14.65% 13/276 |
| 2022 | -24.61% 116/201 |
-4.13% 22/153 |
-16.22% 122/164 |
-10.02% 93/189 |
4.32% 137/202 |
| 2021 | 38.53% 8/150 |
8.18% 38/312 |
10.96% 53/328 |
0.50% 77/358 |
14.83% 3/151 |
| 2020 | -9.61% 70/103 |
-26.35% 236/280 |
10.01% 168/295 |
0.94% 179/299 |
10.51% 114/305 |
| 2019 | 21.62% 40/88 |
15.10% 53/258 |
0.34% 169/268 |
6.42% 17/253 |
-1.05% 247/266 |
| 2018 | -6.66% 33/79 |
- - |
- - |
- - |
-6.92% 82/241 |
| 2017 | 2.95% 55/69 |
- - |
- - |
- - |
- - |
| 2016 | 5.75% 27/59 |
- - |
- - |
- - |
- - |
| 2015 | 0.15% 22/49 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 广发美国房地产指数美元现汇(QDII)A VS. 建信富时100指数(QDII)人民币A(539003) |